There are 2789 resources available
129P - Integration of gene expression and tumor-infiltrating lymphocytes (TILs) to predict pCR after neoadjuvant chemotherapy and nivolumab for patients with luminal B-like breast cancer in the phase II GIADA trial
Presenter: Maria Vittoria Dieci
Session: ePoster Display
130P - Deep learning magnetic resonance imaging radiomics for predicting disease-free survival in patients with early-stage invasive breast cancer
Presenter: Zifan He
Session: ePoster Display
131P - Impact of body mass (BMI) and weight change after adjuvant treatment in patients (pts) with HER2-positive early breast cancer
Presenter: Maria Alice Franzoi
Session: ePoster Display
132P - Health economic properties of palbociclib in breast cancer patients with high risk of relapse following neoadjuvant therapy: Results from the Penelope-B trial
Presenter: Katya Galactionova
Session: ePoster Display
133P - Magnetic resonance imaging radiomics predicts high and low recurrence risk and is associated with LncRNAs in early-stage invasive breast cancer
Presenter: Wei Ren
Session: ePoster Display
134P - Enrolment in clinical trials (CT) among patients (pts) with early breast cancer (BC)
Presenter: Daniele Presti
Session: ePoster Display
135P - Hot flashes during adjuvant hormone therapy predict treatment discontinuation and outcome among breast cancer patients
Presenter: Erwei Zeng
Session: ePoster Display
136P - Assessment of sentinel lymph node biopsy versus axillary lymph node dissection on long-term survival in breast cancer patients with pathologically negative lymph node
Presenter: Shusen Wang
Session: ePoster Display
137P - Trial comparing the safety, efficacy and immunogenicity of trastuzumab biosimilar candidate (TX05) with originator trastuzumab in HER2+ early breast cancer
Presenter: Peter Krivorotko
Session: ePoster Display